FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Search Results

Liraglutide Injection
Status: Currently in Shortage
»Date first posted: 07/18/2023
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Hikma Pharmaceuticals USA, Inc. (New 04/02/2025)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)	Available	Product will be made available as it is released.
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)	Available	Product will be made available as it is released.

Meitheal Pharmaceuticals, Inc. (Reverified 05/16/2025)

Company Contact Information:
844-824-8426

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)	Available
Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)	Available

Novo Nordisk, Inc. (Reverified 06/06/2025)

Company Contact Information:
833-493-4689

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)	Available
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)	Limited Availability	Estimated shortage duration TBD	Delay in shipping of the drug
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)	Limited Availability	Estimated shortage duration TBD	Delay in shipping of the drug
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)	Available	Distributed by Teva
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)	Available	Distributed by Teva